Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis

Journal of Breath Research

Volumn 6, Issue 1, 2012, Pages

  Chow, Sharron ^a   Thomas, Paul S ^a,b   Malouf, Monique ^c   Yates, Deborah H ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; CARBON MONOXIDE; HYDROGEN PEROXIDE; NITRIC OXIDE; 3-NITROTYROSINE; BIOLOGICAL MARKER; DRUG DERIVATIVE; TYROSINE;

ADULT; ARTICLE; BREATHING MECHANICS; CLINICAL ARTICLE; CONTROLLED STUDY; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MALE; NON INVASIVE PROCEDURE; OXIDATIVE STRESS; PH; PNEUMONIA; PRIORITY JOURNAL; BREATH ANALYSIS; EXHALATION; LUNG DISEASE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIROMETRY;

BIOLOGICAL MARKERS; BREATH TESTS; CARBON MONOXIDE; EXHALATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; LUNG DISEASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PULMONARY FIBROSIS; SPIROMETRY; TYROSINE;

EID: 84857543946     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/6/1/016004     Document Type: Article

References (42)

1. American Thoracic Society 2000 Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am. J. Respir. Crit. Care Med. 161 646-64
2. 2002 American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med. 165 277-304
3. Kharitonov S, Alving K and Barnes P J 1997 Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force Eur. Respir. J. 10 1683-93 (Pubitemid 27311092)
4. Kharitonov S A and Barnes P J 2001 Exhaled markers of inflammation Curr. Opin. Allergy Clin. Immunol. 1 217-24
5. Kharitonov S A and Barnes P J 2001 Exhaled markers of pulmonary disease Am. J. Respir. Crit. Care Med. 163 1693-722 (Pubitemid 32578777)
6. Mutlu G M, Garey K W, Robbins R A, Danziger L H and Rubinstein I 2001 Collection and analysis of exhaled breath condensate in humans Am. J. Respir. Crit. CareMed. 164 731-7 (Pubitemid 32881905)
7. Jackson A S, Sandrini A, Campbell C, Chow S, Thomas P S and Yates D H 2007 Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage Am. J. Respir. Crit. Care Med. 175 222-7 (Pubitemid 46203124)
8. Montuschi P 2002 Indirect monitoring of lung inflammation Nature Rev. Drug Discov. 1 238-42 (Pubitemid 37361428)
9. Montuschi P and Barnes P J 2002 Analysis of exhaled breath condensate for monitoring airway inflammation Trends Pharmacol. Sci. 23 232-7 (Pubitemid 34465543)
10. Montuschi P 2007 Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Ther. Adv. Respir. Dis. 1 5-23
11. Psathakis K et al 2006 Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis Eur. J. Clin. Invest. 36 362-7
12. Edme J L et al 2008 Cytokine concentrations in exhaled breath condensates in systemic sclerosis Inflamm. Res. 57 151-6
13. Cantin A M, North S L, Fells G A, Hubbard R C and Crystal R G 1987 Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis J. Clin. Invest. 79 1665-73 (Pubitemid 17117272)
14. Kinnula V L, Fattman C L, Tan R J and Oury T D 2005 Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy Am. J. Respir. Crit. Care Med. 172 417-22 (Pubitemid 41117386)
15. Miller M R et al 2005 Standardisation of spirometry Eur. Respir. J. 26 319-38 (Pubitemid 41079078)
16. Cotes J E, Chinn D J, Quanjer P H, Roca J and Yernault J C 1993 Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur. Respir. J. Suppl. 16 41-52
17. Horvath I et al 2005 Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J. 26 523-48 (Pubitemid 41264218)
18. Misko T P, Schilling R J, Salvemini D, Moore W M and Currie M G 1993 A fluorometric assay for the measurement of nitrite in biological samples Anal. Biochem. 214 11-6 (Pubitemid 23300346)
19. Montuschi P et al 2000 Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis Thorax 55 205-9 (Pubitemid 30245970)
20. Vaughan J et al 2003 Exhaled breath condensate pH is a robust and reproducible assay of airway acidity Eur. Respir. J. 22 889-94 (Pubitemid 37540637)
21. Paredi P, Kharitonov S A, Loukides S, Pantelidis P, du Bois R M and Barnes P J 1999 Exhaled nitric oxide is increased in active fibrosing alveolitis Chest 115 1352-6 (Pubitemid 29230646)
22. Sandrini A, Johnson A R, Thomas P S and Yates D H 2006 Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques Respirology 11 325-9
23. Krishnan A et al 2006 Exhaled breath condensate biomarker analysis: a non-invasive diagnostic tool after lung transplantation? J. Heart Lung Transplant. 25 65
24. Brugiere O et al 2005 Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome Eur. Respir. J. 25 813-9
25. 4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis Thorax 62 602-7
26. Liu J, Conrad D H, Chow S, Tran V H, Yates D H and Thomas P S 2007 Collection devices influence the constituents of exhaled breath condensate Eur. Respir. J. 30 807-8 (Pubitemid 351194845)
27. Ojoo J C, Mulrennan S A, Kastelik J A, Morice A H and Redington A E 2005 Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis Thorax 60 22-6 (Pubitemid 40101013)
28. Chow S, Campbell C, Sandrini A, Thomas P S, Johnson A R and Yates D H 2009 Exhaled breath condensate biomarkers in asbestos-related lung disorders Respir. Med. 103 1091-7
29. Schleiss M B, Holz O, Behnke M, Richter K, Magnussen H and Jorres R A 2000 The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate Eur. Respir. J. 16 1115-8 (Pubitemid 32148127)
30. Montuschi P et al 1998 8-isoprostane as a biomarker of oxidative stress in interstitial lung diseases Am. J. Respir. Crit. Care Med. 158 1524-7
31. Anaev E, Avdeev S, Cherniak A and Merzhoeva Z 2005 Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis European Respiratory Society Int. Conf. (Copenhagen, 2005) p 2192
32. Leung T F, Li C Y, Yung E, Liu E K, Lam C W and Wong G W 2006 Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate Pediatr. Pulmonol. 41 87-94 (Pubitemid 43117373)
33. Carpenter C T, Price P V and Christman B W 1998 Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS Chest 114 1653-9 (Pubitemid 128487489)
34. 2 measurements in exhaled breath condensate Inflamm. Res. 52 502-7
35. 2 in patients with stable and unstable cystic fibrosis Free Radic. Biol. Med. 45 913-9
36. Barreto M, Villa M P, Olita C, Martella S, Ciabattoni G and Montuschi P 2009 8-isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents Chest 135 66-73
37. Montuschi P, Nightingale J A, Kharitonov S A and Barnes P J 2002 Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide Free Radic. Biol. Med. 33 1403-8 (Pubitemid 35284923)
38. Liu L et al 2009 Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children Environ. Health Perspect. 117 668-74
39. 4 in exhaled breath condensate Rapid Commun. Mass Spectrom. 18 2723-9
40. 4 in asthmatic children Respir. Res. 6 119
41. 4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation J. Chromatogr. B 877 1272-80
42. Montuschi P et al 2010 Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma Chest 137 790-6